Manchester, United Kingdom

Bohdan Waszkowycz

This inventor holds 11 USPTO granted patents and 6 published patent applications and 5 EPO patents. Top assignees: Cancer Research Technology Limited, Glaxosmithkline Intellectual Property Development Limited, Sanofi. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bohdan Waszkowycz. Retrieved from https://idiyas.com/inventor/bohdan-waszkowycz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 11 

% Patents Active = 90.9

 

Average Co-Inventor Count = 7.1

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2019-2026

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Bohdan Waszkowycz: Innovator in Pharmaceutical Compounds

Introduction

Bohdan Waszkowycz is a prominent inventor based in Manchester, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific enzyme activities. With a total of 10 patents to his name, his work has implications for the treatment of various proliferative disorders, including cancer.

Latest Patents

Among his latest patents, Waszkowycz has developed PARG inhibitory compounds. This invention relates to compounds that function as inhibitors of the PARG (Poly ADP-ribose glycohydrolase) enzyme activity. The compounds are designed to be used in pharmaceutical compositions for treating diseases where PARG activity is implicated. Another notable patent involves compounds useful as RET inhibitors, which target the RET (rearranged during transfection) kinase enzyme activity. These compounds also have potential applications in treating proliferative disorders and other conditions associated with RET kinase activity.

Career Highlights

Throughout his career, Waszkowycz has worked with notable organizations such as Cancer Research Technology Limited and GlaxoSmithKline Intellectual Property Development Limited. His experience in these companies has allowed him to advance his research and contribute to the development of innovative pharmaceutical solutions.

Collaborations

Waszkowycz has collaborated with several professionals in his field, including Allan Michael Jordan and Rebecca Newton. These collaborations have further enriched his research and development efforts.

Conclusion

Bohdan Waszkowycz is a distinguished inventor whose work in pharmaceutical compounds has the potential to impact the treatment of serious health conditions. His innovative patents and collaborations highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…